Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2011 Nov 10;32(2):516–522. doi: 10.1161/ATVBAHA.111.237040

Figure 1.

Figure 1

Kaplan-Meier analysis for 3-year major adverse cardiac events stratified according to serum ceruloplasmin quartiles (A); and for groups stratified by high/low serum ceruloplasmin (<22 mg/dL vs ≥22 mg/dL) and high/low plasma myeloperoxidase levels (<322 pg/mL vs ≥322 pg/mL) (B). Abbreviations: Cp, ceruloplasmin; Q, quartile; H, high; L, low; MPO, myeloperoxidase.